gross law logo pr.jpg
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 2, 2024 – (NASDAQ: BCLI)
December 28, 2023 13:07 ET | The Gross Law Firm
NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Brainstorm Cell Therapeutics Inc. Shareholders who purchased shares of BCLI during the...
BGG Logo.jpg
BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
December 27, 2023 10:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been...
Photo 1
BRAINSTORM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Brainstorm To Contact Him Directly To Discuss Their Options
December 27, 2023 09:30 ET | Faruqi & Faruqi LLP
If you suffered losses exceeding $25,000 investing in Brainstorm securities between August 15, 2022 and September 27, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 26, 2023 12:07 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 26, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
logo 600X600.png
Introducing Coherent Insights Vault: Pioneering Market Research Growth through Subscriptions
December 26, 2023 11:08 ET | CMI
Burlingame, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Coherent Market Insights proudly introduces the Coherent Insights Vault, a revolutionary subscription model, designed to empower businesses with the...
DEADLINE ALERT for DCGO, SEDG, BCLI, BCS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
December 26, 2023 09:00 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm – BCLI
December 25, 2023 17:10 ET | The Rosen Law Firm PA
NEW YORK, Dec. 25, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between...
July 30, 2021 - ROSEN LOGO.jpg
值得信賴的投資者法律顧問 ROSEN 鼓勵蒙受損失的 Brainstorm Cell Therapeutics Inc. 投資者在該所對 BCLI 首次提起集體訴訟的重要截止日期 1 月 2 日前聘請律師
December 25, 2023 17:10 ET | The Rosen Law Firm PA
紐約, Dec. 26, 2023 (GLOBE NEWSWIRE) -- 事因:全球投資者權益律所 Rosen Law Firm 提醒於 2022 年 8 月 15 日至 2023 年 9 月 27 日期間(含上述兩日,簡稱「集體訴訟期」)購買 Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)...
BES_Mark.jpg
BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
December 24, 2023 21:00 ET | Bragar Eagel & Squire
NEW YORK, Dec. 24, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
December 22, 2023 11:11 ET | Pomerantz LLP
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Brainstorm Cell Therapeutics Inc. (“Brainstorm” or the “Company”) (NASDAQ: BCLI).   Such...